Angene Chemical
Draw
|
Currency :
Home Products

AG003QLK

530-78-9 | Flufenamic acid

Chemical structure of Flufenamic acid, CAS 530-78-9
AG003QLK
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 530-78-9
Catalog Number AG003QLK(AGN-PC-07Y4LE)
Chemical Name Flufenamic acid
EC Number 208-494-1
IUPAC Name 2-[3-(trifluoromethyl)anilino]benzoic acid
InChI InChI=1S/C14H10F3NO2/c15-14(16,17)9-4-3-5-10(8-9)18-12-7-2-1-6-11(12)13(19)20/h1-8,18H,(H,19,20)
InChI Key LPEPZBJOKDYZAD-UHFFFAOYSA-N
MDL Number MFCD00002422
Molecular Formula C14H10F3NO2
Molecular Weight 281.2299
SMILES O=C(O)C1=CC=CC=C1NC2=CC=CC(C(F)(F)F)=C2
UNII 60GCX7Y6BH
Synonyms
Acid, Flufenamic, Dignodolin, Flufenamic Acid, flufenamic acid, 530-78-9, Fluphenamic acid, Nichisedan, Achless, Arlef, N-(3-Trifluoromethylphenyl)anthranilic acid, Flufacid, Fullsafe, Lanceat, Paraflu, Plostene, Tecramine, Parlef, Parlif, Surika, Flufenaminsaeure, Reumajust A, Acido flufenamico, Ristogen, Sastridex, Ansatin, Meralen, 2-((3-(Trifluoromethyl)phenyl)amino)benzoic acid, Fluore-200, 2-{[3-(trifluoromethyl)phenyl]amino}benzoic acid, ANT-1, Acide flufenamique, Acidum flufenamicum, TVX 916, INF 1837, 3'-Trifluoromethyldiphenylamine-2-carboxylic acid, CI 440, NSC-82699, Flufenaminsaeure [German], C.I. 440, CN-27,554, UNII-60GCX7Y6BH, Benzoic acid, 2-[[3-(trifluoromethyl)phenyl]amino]-, Acido flufenamico [Italian], NSC 219007, CCRIS 5266, 2-[[3-(Trifluoromethyl)phenyl]amino]benzoic acid, C14H10F3NO2, Acide flufenamique [INN-French], Acido flufenamico [INN-Spanish], Acidum flufenamicum [INN-Latin], 2-[3-(Trifluoromethyl)anilino]benzoic acid, INF-1837, 2-((3-Trifluromethyl)phenyl)aminobenzoic acid, 2-[[3-(TRIFLUOROMETHYL)PHENYL]AMINO] BENZOIC ACID, EINECS 208-494-1, MFCD00002422, N-(m-Trifluoromethylphenyl)-2-aminobenzoic acid, Flufenamic acid [USAN:INN:BAN:JAN], BRN 1996069, 60GCX7Y6BH, Benzoic acid, 2-((3-(trifluoromethyl)phenyl)amino)-, CHEMBL23588, N-(alpha,alpha,alpha-Trifluoro-m-tolyl)anthranilic acid, MLS000028563, CHEBI:42638, N-[3-(Trifluoromethyl)phenyl]anthranilic acid, LPEPZBJOKDYZAD-UHFFFAOYSA-N, Saal-F, NCGC00016490-06, CAS-530-78-9, Flufenamic acid, 97%, SMR000059027, N-(3-Trifluoromethylphenyl)-anthranilic acid, DSSTox_CID_3063, WLN: QVR BMR CXFFF, DSSTox_RID_76859, DSSTox_GSID_23063, FFA, Anthranilic acid, N-(alpha,alpha,alpha-trifluoro-m-tolyl)-, FLF, 2-[(3-Trifluromethyl)phenyl]aminobenzoic acid, N-[(3-Trifluoromethyl)phenyl]anthranilic acid, N-((m-Trifluoromethyl)phenyl)-2-aminobenzoic acid, N-[(m-Trifluoromethyl)phenyl]-2-aminobenzoic acid, N-[m-(Trifluoromethyl)phenyl]-2-aminobenzoic acid, SR-01000000241, Anthranilic acid,.alpha.,.alpha.-trifluoro-m-tolyl)-, N-(.alpha.,.alpha.-Trifluoro-m-tolyl)anthranilic acid, flufenamic-acid, Prestwick_220, Arlef (TN), Spectrum_001257, 1bm7, 2-(3-Trifluoromethylanilino)benzoic Acid, Opera_ID_578, Prestwick0_000203, Prestwick1_000203, Prestwick2_000203, Prestwick3_000203, Spectrum2_000789, Spectrum3_001273, Spectrum4_000102, Spectrum5_000686, EC 208-494-1, AC1L1FS8, CBiol_001756, SCHEMBL17497, BSPBio_000185, BSPBio_001319, BSPBio_002866, CBDivE_012649, KBioGR_000039, KBioGR_000424, KBioGR_002267, KBioSS_000039, KBioSS_001737, KBioSS_002268, 3-14-00-00905 (Beilstein Handbook Reference), KSC911Q2R, MLS001148610, DivK1c_000581, SPECTRUM1501015, SPBio_000898, SPBio_002106, ACMC-209l43, AC1Q72G6, BPBio1_000205, GTPL2447, DTXSID7023063, BCBcMAP01_000039, BDBM17636, CTK8B1828, HMS501N03, KBio1_000581, KBio2_000039, KBio2_001737, KBio2_002267, KBio2_002607, KBio2_004305, KBio2_004835, KBio2_005175, KBio2_006873, KBio2_007403, KBio3_000077, KBio3_000078, KBio3_002366, KBio3_002747, ZINC86535, cMAP_000004, NINDS_000581, Bio1_000042, Bio1_000531, Bio1_001020, Bio2_000039, Bio2_000519, Flufenamic acid (JAN/USAN/INN), HMS1361B21, HMS1568J07, HMS1791B21, HMS1921B21, HMS1989B21, HMS2089E07, HMS2092B09, HMS2095J07, HMS2232G24, HMS3371F01, HMS3402B21, HMS3652F06, HMS3712J07, Pharmakon1600-01501015, HY-B1221, KS-000015VF, NSC82699, Tox21_110452, Tox21_302111, ANW-31633, BBL001490, CCG-40167, HTS000643, NSC219007, NSC757823, s4268, SBB001140, STK985630, AKOS000265536, Tox21_110452_1, CS-4811, DB02266, KS-1143, MCULE-8606118307, NE10194, NSC-219007, NSC-757823, IDI1_000581, IDI1_033789, NCGC00016490-01, NCGC00016490-02, NCGC00016490-03, NCGC00016490-04, NCGC00016490-05, NCGC00016490-07, NCGC00016490-08, NCGC00016490-09, NCGC00016490-10, NCGC00016490-12, NCGC00023200-03, NCGC00023200-04, NCGC00023200-05, NCGC00023200-06, NCGC00023200-07, NCGC00255175-01, AJ-10755, AK143107, AN-16724, BC207258, CN-27544, CN-27554, LS-20583, M456, SC-17641, ST026563, N-(3-Trifluoromethylphenyl)anthranilicAcid, SBI-0051633.P002, RT-000369, 2-[3-(trifluoromethyl)anilino]-benzoic acid, AB00052198, FT-0603454, n-(a,a,a-trifluoro-m-tolyl)anthranilic acid, ST24038963, SW196528-3, UNM000001246003, 2-[3-(Trifluoromethyl)anilino]benzoic acid #, 2-(3-(trifluoromethyl)phenylamino)benzoic acid, 2-[(3-Trifluoromethylphenyl)amino]benzoic Acid, A13333, C13038, D01581, AB00052198-14, AB00052198_15, 530F789, SR-01000000241-2, SR-01000000241-3, W-105772, BRD-K44067360-001-06-3, BRD-K44067360-001-16-2, I14-19098, F0909-0007, Flufenamic acid, analytical standard, for drug analysis, N-(.alpha.,.alpha.,.alpha.-Trifluoro-m-tolyl)anthranilic acid, Anthranilic acid, N-(.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-, Flufenamicacid, Dignodolin, Acid, Flufenamic, D0B2WJ, CID3371, C14-H10-F3-N-O2, CI-440, Flufenamic acid [USAN:BAN:INN:JAN], B1760, T2354, D005439, N-(alpha,alpha,alpha-trifluoro-m-tolyl)anthra-nilic acid, Flufenamic acid, 97%, an anti-inflammatory agent - 10G 10g,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited